Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 17.39 percent decrease over losses of $(0.23) per share from the same period last year.
4 Experts Agree Following CPI Inflation Print: Housing Appears To Be Inflating Data, But The Fed Will Not Be Fooled
The Labor Department on Tuesday reported a 6% year-over-year increase in the consumer price index (CPI) for February.
